XML 28 R18.htm IDEA: XBRL DOCUMENT
v3.22.1

Share-Based Compensation | 3 Months Ended
--- | ---
Mar. 31, 2022
Share-based Payment Arrangement [Abstract] |
Share-Based Compensation | Share-Based Compensation The Company has four share-based compensation plans as described below. Share-based compensation cost recognized for those plans was $97,000 and $101,000 for the three months ended March 31, 2022 and 2021, respectively. The recognized tax (benefit) expense for the share-based compensation expense, forfeitures of restricted stock, and exercise of stock options, resulted in the recognition of $(22,000) and $1,000, respectively, for the three months ended March 31, 2022 and 2021. The Central Valley Community Bancorp 2005 Omnibus Incentive Plan (2005 Plan) was adopted in May 2005 and expired March 16, 2015. In October 2017, the Company assumed the Folsom Lake Bank 2007 Equity Incentive Plan (2007 Plan). While outstanding arrangements to issue shares under these plans, including options, continue in force until their expiration, no new options will be granted under these plans. The Central Valley Community Bancorp 2015 Omnibus Incentive Plan (2015 Plan) was adopted in May 2015. The plan provides for awards in the form of incentive stock options, non-statutory stock options, stock appreciation rights, and restricted stock. The plan also allows for performance awards that may be in the form of cash or shares of the Company, including restricted stock. Outstanding arrangements to issue shares under this plan including options, will continue in force until expiration according to their respective terms. Effective June 2, 2017, the Company adopted an Employee Stock Purchase Plan (ESPP) whereby our employees may purchase Company common stock through payroll deductions of between one percent and 15 percent of pay in each pay period. Shares are purchased at the end of each of the three-month offering periods at a 10 percent discount from the lower of the closing market price on the Offering Date (first trading day of each offering period) or the Investment Date (last trading day of each offering period). The Company reserved 500,000 common shares to be set aside for the ESPP, and there were 442,401 shares available for future purchase under the plan as of March 31, 2022. Stock Option Plan The Company bases the fair value of the stock options granted on the date of grant using a Black-Scholes Merton option pricing model that uses assumptions based on expected option life and the level of estimated forfeitures, expected stock volatility, risk free interest rate, and dividend yield. The expected term and level of estimated forfeitures of the Company’s stock options are based on the Company’s own historical experience. Stock volatility is based on the historical volatility of the Company’s stock. The risk-free interest rate is based on the U. S. Treasury yield curve for the periods within the contractual life of the stock options in effect at the time of grant. The compensation cost for stock options granted is based on the weighted average grant date fair value per share. No options to purchase shares of the Company’s common stock were granted during the three months ended March 31, 2022 and 2021. A summary of the combined activity of the Company’s stock option compensation plans for the three months ended March 31, 2022 follows (in thousands, except per share amounts):
|  | Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term (Years) |  | Aggregate Intrinsic Value
Options outstanding at December 31, 2021 |  | 52,805 |  |  | $ | 9.81 |  |  |  |  |
Options exercised |  | (11,075) |  |  | $ | 11.87 |  |  |  |  |
Options forfeited |  | (1,800) |  |  | $ | 12.50 |  |  |  |  |
Options outstanding at March 31, 2022 |  | 39,930 |  |  | $ | 9.12 |  |  | 0.38 |  | $ | 566 |
Options vested or expected to vest at March 31, 2022 |  | 39,930 |  |  | $ | 9.12 |  |  | 0.38 |  | $ | 566 |
Options exercisable at March 31, 2022 |  | 39,930 |  |  | $ | 9.12 |  |  | 0.38 |  | $ | 566 |
Information related to the stock option plan is as follows (in thousands):
|  | For the Three Months Ended March 31, |  |
|  | 2022 |  | 2021 |  |  |  |
Intrinsic value of options exercised |  | $ | 118 |  |  | $ | 1 |  |  |  |  |
Cash received from options exercised |  | $ | 132 |  |  | $ | 1 |  |  |  |  |
Excess tax benefit realized for option exercises |  | $ | 22 |  |  | $ | — |  |  |  |  |
As of March 31, 2022, there was no remaining unrecognized compensation cost related to stock options granted under all plans. Restricted and Performance Common Stock Awards The 2015 Plan provides for the issuance of restricted common stock to directors and officers. In addition, performance awards may be granted in the form of cash or shares. Restricted common stock grants typically vest over a one to five-year period. Restricted common stock (all of which are shares of our common stock) is subject to forfeiture if employment terminates prior to vesting. The cost of these awards is recognized over the vesting period of the awards based on the fair value of our common stock on the date of the grant. The following table summarizes restricted stock and performance award activity for the three months ended March 31, 2022 as follows:
|  | Shares |  | Weighted Average Grant-Date Fair Value
Nonvested outstanding shares at December 31, 2021 |  | 24,177 |  |  | $ | 20.50 |
Granted |  | 17,847 |  |  | $ | 21.25 |
Vested |  | (13,355) |  |  | $ | 20.75 |
Forfeited |  | (83) |  |  | $ | 19.99 |
Nonvested outstanding shares at March 31, 2022 |  | 28,586 |  |  | $ | 20.86 |
The shares awarded to employees and directors under the restricted stock agreements vest on applicable vesting dates only to the extent the recipient of the shares is then an employee or a director of the Company or one of its subsidiaries, and each recipient will forfeit all of the shares that have not vested on the date his or her employment or service is terminated. Performance common stock awards vest immediately. As of March 31, 2022, there were 28,586 shares of restricted stock that are nonvested and expected to vest. As of March 31, 2022, there was $284,000 of total unrecognized compensation cost related to nonvested restricted common stock awards. Restricted stock compensation expense is recognized on a straight-line basis over the vesting period. This cost is expected to be recognized over a weighted-average remaining period of 2.84 years and will be adjusted for subsequent changes in estimated forfeitures. Restricted common stock awards had an intrinsic value of $3,432,000 at March 31, 2022.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration